Tobramycin Injection
Product Images NDC 68083-253

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 68083-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobramycin-spl-10-mg-carton-label (Tobramycin Spl 10 mg Carton Label)

Packaging label for Tobramycin Injection, USP 20 mg/2 mL (10 mg/mL) pediatric injection multiple dose vials, manufactured by Gland Pharma Limited. Each vial contains 2 mL of injection for intramuscular or intravenous use, with instructions to dilute for intravenous use. The label includes dosage, storage information, and manufacturer details with a barcode and batch details area.*

FDA Label Image

Tobramycin-spl-10-mg-vial-label (Tobramycin Spl 10 mg Vial Label)

Tobramycin Injection, USP 20 mg/2 mL (10 mg/mL) pediatric vial label. The label indicates the product is for intramuscular or intravenous use and must be diluted for intravenous use. It is a 2 mL multiple dose vial manufactured by Gland Pharma Limited, India. The label includes a bar code, lot number, and expiration date area.*

FDA Label Image

Tobramycin-spl-40-mg-carton-label (Tobramycin Spl 40 mg Carton Label)

The label for Tobramycin Injection, USP 80 mg/2 mL (40 mg/mL) from Gland Pharma Limited. It specifies the product as a multiple dose vial pack of 25 x 2 mL vials for intramuscular or intravenous use, requiring dilution for intravenous administration. The label includes storage instructions, ingredient details, an NDC code (68083-254-25), and a barcode.*

FDA Label Image

Tobramycin-spl-40-mg-vial-label (Tobramycin Spl 40 mg Vial Label)

Tobramycin Injection, USP 80 mg/2 mL (40 mg/mL) label for a 2 mL multiple dose vial. The label states the product is for intramuscular or intravenous use and must be diluted for intravenous use. It is manufactured by Gland Pharma Limited in Hyderabad, India. The label includes an NDC barcode and spaces for lot and expiration dates.*

FDA Label Image

Tobramycin-spl-figure (Tobramycin Spl Figure)

A line graph titled 'REDUCED DOSAGE NOMOGRAM' showing the relationship between serum creatinine levels (mg/100 mL) on the x-axis and percent of normal dosage from Table 3 on the y-axis. The top x-axis indicates creatinine clearance (mL/min/1.73 m2). The graph line ascends linearly, depicting dosage reduction according to creatinine clearance and serum creatinine values.*

FDA Label Image

Tobramycin-spl-structure (Tobramycin Spl Structure)

Chemical structure of the active ingredient Tobramycin, showing its molecular composition with rings and attached amino, hydroxyl, and other functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.